In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential, based on recent research conducted by ZS on the top 25 pharma companies.


Key takeaways:

  • Pharma's shift toward “doing more with less” has driven a focus on leaner models that prioritize systemic excellence, leading to increased operational efficiency.
  • The evolution of commercial excellence functions within the industry has seen them expand their scope beyond traditional boundaries.
  • The commercial excellence function holds the potential to deliver distinctive value across diverse business priorities.